glp 1 agonist peptide GLP-1 Receptor Agonists – Peripheral Brain Glucagon-like peptide 1 in health

However, diabetes itself predisposes individuals to neuropathy, potentially confounding the association between GLP-1 RAs and NAEs

2016a;39:23141

Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications primarily used for managing type 2 diabetes mellitus and, more recently, for chronic weight management

Subgroup analyses (Figure 3) (exploratory and not powered for formal interaction testing) showed generally consistent trends across most categories

62 Similar results are obtained for individuals with obesity and knee OA who took GLP-1 agonists over 68 weeks in a recent study

For instance, retrospective analyses have suggested potential associations with thyroid cancer risk during long-term use [4], whereas studies of pancreatic cancer have yielded contrasting results [68]